Why is Befesa stock rallying today?

US concludes third round of strikes against Iran after Trump reinstates blockade Investing.com -- Befesa stock gained 2.3% to trade at €33.20, lifted by a Morgan Stanley Overweight reiteration that characterized the current price level as a buying...

US concludes third round of strikes against Iran after Trump reinstates blockade Investing.com -- Befesa stock gained 2.3% to trade at €33.20, lifted by a Morgan Stanley Overweight reiteration that characterized the current price level as a buying opportunity, pointing to a EUR 37.00 price target and noting that the stock’s EV/EBITDA multiple had compressed well below the peer group average despite unchanged consensus EBITDA expectations. The bank also highlighted what it viewed as a sector-leading free cash flow yield of approximately 11%, underpinning the investment case. Adding to the positive tone, Befesa’s Q2 2026 earnings are due on July 29, and investors appear to be building positions ahead of the release.

The company’s Q1 2026 results provided a constructive backdrop, with EPS of €0.52 beating analyst estimates by a wide margin and net income rising 11% year-over-year, while management reaffirmed full-year adjusted EBITDA guidance of EUR 250–270 million. The gains came despite a risk-off session in U.S. markets, where the S&P 500 fell 0.8% and the Nasdaq dropped 1.6%, making Befesa’s advance a notably divergent move. The stock’s recovery also reflects a broader technical setup: shares remain roughly 11% below their 52-week high of €37.40, and a sharp decline in short interest through June has reduced selling pressure.

Taken together, the Morgan Stanley endorsement, a clean fundamental setup heading into earnings, and easing short-side pressure combined to push Befesa higher even as global equity markets faced headwinds, with the stock touching an intraday high of €34.10 during the session.